The latest among a number of activities the administration has undertaken to combat antibiotic resistance, the event brought together key human and animal health constituencies involved in antibiotic stewardship.
Read More
The US Department of Health and Human Services has awarded a $10.4 million contract to OraSure Technologies for clinical development of the company’s OraQuick ebola rapid antigen test.
Read MorePhase I SBIR grant for sickle cell disease research supported by scientific data recently published in Pediatric Blood & Cancer.
Read More
Addressing the vast international scope of the infectious disease issue, health policymakers are redefining the important roles that clinical and public health labs play in executing public policies to combat emerging and antibiotic-resistant diseases.
Read MoreSpanning from clinical diagnostics to business strategy, this year’s expanded program encompasses predictive cancer biomarkers, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, cell-free DNA, commercialization, cancer immunotherapy, and reimbursement.
Read More